Two genetic pathways,t(1;10) and amplification of 3p11–12, in myxoinflammatory fibroblastic sarcoma,haemosiderotic fibrolipomatous tumour,and morphologically similar lesions |
| |
| Authors: | Karolin H Hallor,Raf Sciot,Johan Staaf,Markus Heidenblad,Anders Rydholm,Henrik CF Bauer,Kristina str m,Henryk A Domanski,Jeanne M Meis,Lars‐Gunnar Kindblom,Ioannis Panagopoulos,Nils Mandahl,Fredrik Mertens |
| |
| Affiliation: | 1. Department of Clinical Genetics, University Hospital, Lund, Sweden;2. Department of Pathology, Catholic University of Leuven, Leuven, Belgium;3. Department of Oncology, University Hospital, Lund, Sweden;4. Department of Orthopedics, University Hospital, Lund, Sweden;5. Department of Orthopedics, Karolinska Hospital, Stockholm, Sweden;6. Department of Pathology, Karolinska Hospital, Stockholm, Sweden;7. Department of Pathology, University Hospital, Lund, Sweden;8. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;9. Department of Musculoskeletal Pathology, Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, UK |
| |
| Abstract: | |
| |
| Keywords: | myxoinflammatory fibroblastic sarcoma haemosiderotic fibrolipomatous tumour inflammatory malignant fibrous histiocytoma FGF8 NPM3 TGFBR3 VGLL3 t(1 10) ring chromosome |
|
|
